logo

For the Inventor, By the Inventor

West Lafayette, IN, United States of America

David E Nichols

This inventor holds 9 USPTO granted patents. Top assignees: Purdue Research Foundation, The University of North Carolina at Chapel Hill, Other. Active years: 1991-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David E Nichols. Retrieved from https://idiyas.com/inventor/david-e-nichols-2l2lzadt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 66.7

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 46(Granted Patents)


Company Filing History:

goldMedal7 out of 2,785 
 
Purdue Research Foundation
 patents
silverMedal4 out of 1,327 
 
The University of North Carolina at Chapel Hill
 patents
bronzeMedal2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-2016

Loading Chart...
9 patents (USPTO):Explore Patents
1. 9359303 - Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor (2016-06-07),
2. 8318938 - Trans-fused chromenoisoquinolines synthesis and methods for use (2012-11-27),
3. 6916832 - Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands (2005-07-12),
4. 6916823 - Method of treatment of dopamine-related dysfunction (2005-07-12),
5. 6413977 - Chromeno[4,3,2-DE]isoquinolines as potent dopamine receptor ligands (2002-07-02),
6. 6194423 - Fused isoquinolines as dopamine receptor ligands (2001-02-27),
7. 5959110 - Fused isoquinolines as dopamine receptor ligands (1999-09-28),
8. 5420134 - Substituted hexahydrobenzo[A]phenanthridines (1995-05-30),
9. 5047536 - Hexahydrobenzo(A)phenanthridine compounds (1991-09-10),

Title: David E Nichols: Innovator in Dopamine Receptor Modulation

Introduction

David E Nichols is a prominent inventor based in West Lafayette, IN (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate dopamine receptors. With a total of 9 patents to his name, Nichols has established himself as a key figure in the research and application of dopamine-related therapies.

Latest Patents

Among his latest patents, Nichols has developed octahydrobenzoisoquinoline modulators of dopamine receptors. These modulators are described as having potential uses in the treatment of dopamine dysfunction. Additionally, he has worked on the synthesis of trans-fused chromenoisoquinolines, which includes optionally substituted chromenoisoquinolines and their analogs. The methods for using these compounds as dopamine receptor binding agents are also detailed in his patents.

Career Highlights

Throughout his career, Nichols has been associated with reputable institutions such as the Purdue Research Foundation and the University of North Carolina at Chapel Hill. His work has focused on advancing the understanding of dopamine receptors and their implications in various neurological conditions.

Collaborations

Nichols has collaborated with notable colleagues in his field, including Richard B Mailman and Russell A Grubbs. These partnerships have contributed to the advancement of research in dopamine receptor modulation and its therapeutic applications.

Conclusion

David E Nichols is a distinguished inventor whose work in dopamine receptor modulation has the potential to impact the treatment of various neurological disorders. His innovative patents and collaborations highlight his commitment to advancing pharmacological research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…